NYSE:RFL Rafael (RFL) Stock Forecast, Price & News $1.99 0.00 (0.00%) (As of 09/26/2023 ET) Add Compare Share Share Today's Range$1.95▼$2.0250-Day Range$1.99▼$2.4952-Week Range$1.55▼$2.52Volume41,153 shsAverage Volume18,614 shsMarket Capitalization$48.36 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media About Rafael (NYSE:RFL) StockRafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), that is in Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.Read More RFL Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RFL Stock News HeadlinesSeptember 26, 2023 | uk.news.yahoo.com‘I’d love to see Rafael Nadal play one more time – he’s a student of the game’, says tennis greatSeptember 26, 2023 | msn.comRafael Fiziev Clears the Air on His Fight-Ending Injury at UFC Fight Night 228September 27, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...September 26, 2023 | americanbankingnews.comContrasting Rafael (NYSE:RFL) & Ellington Financial (NYSE:EFC)September 25, 2023 | msn.comSaudi Pro League transfer news: Rafael Leao provides latest transfer update amid Liverpool & Real Madrid interestSeptember 25, 2023 | msn.comRafael Fiziev Suffers Knee Injury To Cut Main Event ShortSeptember 25, 2023 | uk.movies.yahoo.com‘Novak Djokovic is the perfect athlete for tennis – his body was more ready to last than Rafael Nadal’September 24, 2023 | msn.comSean Shelby's Shoes: What's next for Rafael Fiziev after UFC Fight Night 228 injury TKO loss?September 27, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...September 24, 2023 | msn.comRafael Fiziev on Gamrot : “Take me down 200 times, I am ready to stand up 201.”September 24, 2023 | sports.yahoo.comSocial media reacts to Mateusz Gamrot’s injury TKO win over Rafael Fiziev at UFC Fight Night 228September 24, 2023 | msn.comUFC Fight Night Results & Highlights: Mateusz Gamrot Defeats Rafael Fiziev Via Injury-Stoppage TKOSeptember 24, 2023 | msn.comUFC Vegas 79 main event fizzles after Rafael Fiziev injures knee in TKO loss to Mateusz GamrotSeptember 24, 2023 | msn.comMateusz Gamrot vs. Rafael Fiziev full fight video highlightsSeptember 24, 2023 | msn.com3 Positives & 4 Negatives From UFC Fight Night: Rafael Fiziev vs. Mateusz GamrotSeptember 24, 2023 | msn.comUFC Fight Night results, highlights: Mateusz Gamrot scores TKO win after Rafael Fiziev suffers leg injurySeptember 24, 2023 | msn.comUFC Fight Night 228 results: Mateusz Gamrot gets TKO win from Rafael Fiziev injurySeptember 23, 2023 | msn.comUFC Vegas 79 weigh-in results: Rafael Fiziev, Mateusz Gamrot set for contender clashSeptember 23, 2023 | msn.comUFC Fight Night 228: Rafael Fiziev vs. Mateusz Gamrot odds, picks and predictionsSeptember 23, 2023 | msn.comRafael Nadal hails 'best in history' Novak DjokovicSeptember 23, 2023 | msn.comUFC Fight Night: Rafael Fiziev vs. Mateusz Gamrot Results & Highlights (4PM ET)September 22, 2023 | msn.comUFC Fight Night: Rafael Fiziev vs. Mateusz Gamrot Weigh-In Results: All 22 Make WeightSeptember 22, 2023 | msn.comRafael Fiziev Looks To Get Back In Win ColumnSeptember 22, 2023 | msn.comUFC Vegas 79 preview show: Who needs the win more, Rafael Fiziev or Mateusz Gamrot?September 22, 2023 | msn.comUFC Fight Night: Will Rafael Fiziev get back in the win column against Mateusz Gamrot?September 22, 2023 | msn.comRafael Fiziev believes Conor McGregor ‘lost focus’ ahead of return, believes controlled Michael Chandler beats him ‘easily’September 22, 2023 | msn.comUFC Fight Night: Rafael Fiziev vs. Mateusz Gamrot Weigh-In Live Stream & Results (12 PM ET)See More Headlines Receive RFL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rafael and its competitors with MarketBeat's FREE daily newsletter. Email Address RFL Company Calendar Last Earnings3/12/2019Today9/27/2023Next Earnings (Estimated)10/30/2023Fiscal Year End7/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Real estate Sub-IndustryN/A SectorMedical Current SymbolNYSE:RFL CUSIPN/A CIK1713863 Webwww.rafaelholdings.com Phone(212) 658-1450FaxN/AEmployees22Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.37) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-124,660,000.00 Net Margins-2,813.93% Pretax Margin-5,304.65% Return on Equity-14.63% Return on Assets-13.65% Debt Debt-to-Equity RatioN/A Current Ratio60.28 Quick Ratio60.27 Sales & Book Value Annual Sales$410,000.00 Price / Sales117.94 Cash FlowN/A Price / Cash FlowN/A Book Value$3.97 per share Price / Book0.50Miscellaneous Outstanding Shares24,300,000Free Float22,254,000Market Cap$48.36 million OptionableOptionable Beta1.62 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Howard S. Jonas (Age 67)Founder & Chairman Comp: $223.75kMr. William Conkling (Age 51)Chief Exec. Officer Comp: $707.5kMr. David A. Polinsky Esq. (Age 51)Chief Financial Officer Ms. Barbara A. Ryan (Age 63)Investor Relations Officer Mr. Gus KodershaChief Technical Operations OfficerDr. Rick EwingHead of Drug DiscoveryMs. Joyce J. Mason Esq. (Age 64)Corp. Sec. More ExecutivesKey CompetitorsStreamline Health SolutionsNASDAQ:STRMVivani MedicalNASDAQ:VANISELLAS Life Sciences GroupNASDAQ:SLSImmunoPrecise AntibodiesNASDAQ:IPAOKYO PharmaNASDAQ:OKYOView All CompetitorsInstitutional OwnershipOsaic Holdings Inc.Bought 20,400 shares on 8/21/2023Ownership: 0.131%Citadel Advisors LLCSold 4,600 shares on 8/15/2023Ownership: 0.000%Renaissance Technologies LLCSold 51,368 shares on 8/11/2023Ownership: 0.557%Geode Capital Management LLCBought 28,717 shares on 8/11/2023Ownership: 0.498%Osaic Holdings Inc.Bought 20,400 shares on 8/10/2023Ownership: 0.131%View All Institutional Transactions RFL Stock - Frequently Asked Questions How have RFL shares performed in 2023? Rafael's stock was trading at $1.87 at the beginning of 2023. Since then, RFL stock has increased by 6.4% and is now trading at $1.99. View the best growth stocks for 2023 here. Are investors shorting Rafael? Rafael saw a decrease in short interest in August. As of August 31st, there was short interest totaling 72,000 shares, a decrease of 21.5% from the August 15th total of 91,700 shares. Based on an average daily volume of 23,700 shares, the short-interest ratio is currently 3.0 days. Approximately 0.5% of the shares of the company are sold short. View Rafael's Short Interest. When is Rafael's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023. View our RFL earnings forecast. How were Rafael's earnings last quarter? Rafael Holdings, Inc. (NYSE:RFL) announced its quarterly earnings data on Tuesday, March, 12th. The company reported ($0.08) earnings per share for the quarter. The company had revenue of $1.02 million for the quarter. Rafael had a negative trailing twelve-month return on equity of 14.63% and a negative net margin of 2,813.93%. What is Rafael's stock symbol? Rafael trades on the New York Stock Exchange (NYSE) under the ticker symbol "RFL." Who are Rafael's major shareholders? Rafael's stock is owned by a number of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (1.60%), Kahn Brothers Group Inc. (1.13%), Renaissance Technologies LLC (0.56%), Geode Capital Management LLC (0.50%), Osaic Holdings Inc. (0.13%) and Osaic Holdings Inc. (0.13%). View institutional ownership trends. How do I buy shares of Rafael? Shares of RFL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Rafael's stock price today? One share of RFL stock can currently be purchased for approximately $1.99. How much money does Rafael make? Rafael (NYSE:RFL) has a market capitalization of $48.36 million and generates $410,000.00 in revenue each year. The company earns $-124,660,000.00 in net income (profit) each year or ($0.37) on an earnings per share basis. How can I contact Rafael? Rafael's mailing address is 520 BROAD STREET, NEWARK NJ, 07102. The official website for the company is www.rafaelholdings.com. The company can be reached via phone at (212) 658-1450 or via email at invest@rafaelholdings.com. This page (NYSE:RFL) was last updated on 9/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rafael Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.